Genfine Nets $15M In Series B
12/13/21, 7:57 AM
Location
beijing
Money raised
$15 million
Round Type
series b
Beijing-headquartered Genfine Biotech (Beijing) Co., Ltd has raised 100 million yuan ($15 million) in its Series B round of financing jointly led by state-backed China Merchants Group’s China Merchants Securities (CMS) and China Merchants Securities Capital (CMSC), per a company statement.